19992020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

Eggermont, A. M. M., Kicinski, M., Blank, C. U., Mandala, M., Long, G. V., Atkinson, V., Dalle, S., Haydon, A., Khattak, A., Carlino, M. S., Sandhu, S., Larkin, J., Puig, S., Ascierto, P. A., Rutkowski, P., Schadendorf, D., Koornstra, R., Hernandez-Aya, L., di Giacomo, A. M., van den Eertwegh, A. J. M. & 10 others, Grob, J-J., Gutzmer, R., Jamal, R., Lorigan, P. C., Krepler, C., Ibrahim, N., Marreaud, S., van Akkooi, A., Robert, C. & Suciu, S., 2 Jan 2020, In : JAMA Oncology. 6, 4, 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Surgery for unresectable stage IIIC and IV melanoma in the era of new systemic therapy

Blankenstein, S. A., Aarts, M. J. B., Van Den Berkmortel, F. W. P. J., Boers-Sonderen, M. J., Van Den Eertwegh, A. J. M., Franken, M. G., De Groot, J. W. B., Haanen, J. B. A. G., Hospers, G. A. P., Kapiteijn, E., Piersma, D., Van Rijn, R. S., Suijkerbuijk, K. P. M., Ten Tije, A. J., Van Der Veldt, A. A. M., Vreugdenhil, G., Wouters, M. W. J. M. & Van Akkooi, A. C. J., May 2020, In : Cancers. 12, 5, 1176.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Systematic Review on Infusion Reactions to and Infusion Rate of Monoclonal Antibodies Used in Cancer Treatment

Rombouts, M. D., Swart, E. L., VAN DEN Eertwegh, A. J. M. & Crul, M., Mar 2020, In : Anticancer Research. 40, 3, p. 1201-1218 18 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry

Notohardjo, J. C. L., Kuppen, M. C. P., Westgeest, H. M., van Moorselaar, R. J. A., Mehra, N., Coenen, J. L. L. M., van Oort, I. M., de Vos, A. I., Vervenne, W. L., van den Bergh, A. C. M., Aben, K. K. H., Somford, D. M., Bergman, A. M., Uyl-de Groot, C. A., Gerritsen, W. R. & van den Eertwegh, A. J. M., 1 Jan 2020, (Accepted/In press) In : European Urology Focus.

Research output: Contribution to journalArticleAcademicpeer-review

Assessment of simplified methods for quantification of 18F-FDHT uptake in patients with metastatic castration-resistant prostate cancer

Kramer, G. M., Yaqub, M., Vargas, H. A., Schuit, R. C., Windhorst, A. D., van den Eertwegh, A. J. M., van der Veldt, A. A. M., Bergman, A. M., Burnazi, E. M., Lewis, J. S., Chua, S., Staton, K. D., Beattie, B. J., Humm, J. L., Davis, I. D., Weickhardt, A. J., Scott, A. M., Morris, M. J., Hoekstra, O. S. & Lammertsma, A. A., 1 Sep 2019, In : Journal of Nuclear Medicine. 60, 9, p. 1221-1227

Research output: Contribution to journalArticleAcademicpeer-review